Introduction: Teriparatide comprises the first 34 amino acids of parathyroid hormone and is a systemic anabolic agent that is Food and Drug Administration approved for the treatment of osteoporosis but not for periodontitis. To our knowledge, this is the first clinical case report to document the treatment of a patient with severe periodontitis using an open-flap debridement procedure in conjunction with teriparatide.

Case Presentation: A 45-year-old female patient was diagnosed with severe chronic periodontitis, including the presence of an intrabony defect on tooth #6. She received open-flap debridement surgery in conjunction with daily systemic administration of 20 μg teriparatide, oral vitamin D, and calcium supplements for 6 weeks. Radiographic, clinical, gingival crevicular fluid (pyridinoline cross-linked carboxy-terminal propeptide of type I procollagen, procollagen type 1 N-propeptide, and osteocalcin), and serum parameters (parathyroid hormone, bone alkaline phosphatase, calcium, and 25-hydroxyvitamin D) were assessed. Treatment outcomes were evaluated over 4 years, with successful radiographic and clinical results throughout the follow-up period.

Conclusion: Teriparatide administration in conjunction with traditional open-flap debridement surgery offers potential for the treatment of severe intrabony defects resulting from chronic periodontitis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4623592PMC
http://dx.doi.org/10.1902/cap.2012.110043DOI Listing

Publication Analysis

Top Keywords

open-flap debridement
12
teriparatide administration
8
intrabony defect
8
case report
8
parathyroid hormone
8
chronic periodontitis
8
debridement surgery
8
radiographic clinical
8
systemic teriparatide
4
administration
4

Similar Publications

Aim: The present study aimed to evaluate the accuracy of noninvasive cone beam computed tomography (CBCT) in the estimation of periodontal bone defects and compare it with that of measurements obtained by invasive surgical exploration using open flap debridement procedure for the evaluation of bony topography.

Materials And Methods: Bone defects in 384 sites with moderate-to-severe periodontitis from eight patients were considered. Probing depth was measured in the following six sites in the selected teeth: mesiobuccal (MB), mesiopalatal (MP)/mesiolingual (ML), buccal (B), palatal (P)/lingual (L), distobuccal (DB) and distopalatal (DP)/distolingual (DL).

View Article and Find Full Text PDF

CALCIUM PHOSPHATE GRAFTS COMBINED WITH GUIDED TISSUE REGENERATION IN THE TREATMENT OF PERIODONTAL BONY DEFECTS- A SYSTEMATIC REVIEW AND META-ANALYSIS.

J Evid Based Dent Pract

December 2024

Assistant Professor, Department of Restorative Dentistry, Maurice H. Kornberg School of Dentistry, Temple University, Philadelphia, PA.

Background: The objective of this systematic review is to assess the clinical outcomes of intrabony and furcation defects treated using a regenerative approach with calcium phosphate (CP) grafts combined plus guided tissue regeneration (GTR) membrane in comparison to open flap debridement (OFD).

Method: A review protocol was created under PRISMA checklist to find randomized clinical trials (RCTs) in English that compared CPs plus GTR with OFD in humans with intrabony and/or furcation defects. Both electronic and manual searches were conducted.

View Article and Find Full Text PDF

: This study evaluated the outcomes of single open-flap debridement, open-flap debridement (OFD) plus resorbable membrane placement, and OFD with resorbable membrane placement plus platelet-rich fibrin (PRF) in terms of periodontal clinical parameters and glycated hemoglobin (HbA1c) levels in 24 adult patients with stage 3 grade C periodontitis and type II diabetes mellitus. : The primary outcome measure for this study was the clinical attachment level (CAL); secondary outcomes included additional periodontal parameters, such as the plaque index (PI), bleeding on probing (BOP), probing depth (PD), as well as glycated hemoglobin (HbA1c) levels to evaluate the systemic impact of the treatments on glycemic control. The parameters were assessed before and at three and six months post-surgery.

View Article and Find Full Text PDF

Background Periodontitis is a chronic inflammatory disease that alters the alveolar bone structure, requiring treatment ranging from non-surgical to surgical periodontal therapies based on its severity. Surgical interventions, such as the modified Widman flap procedure and the open flap technique combined with methods like platelet-rich fibrin (PRF), guided tissue regeneration (GTR), and bone grafts, aim to reduce periodontal pockets and regenerate lost tissues. The presence of pathogenic bacteria and the absence of beneficial bacteria contribute to periodontitis, with probiotics-live microorganisms that offer health benefits emerging as a promising adjunct in periodontal therapy.

View Article and Find Full Text PDF

To provide an overview of the use of autogenous platelet concentrates (APCs) in periodontal regeneration and to conduct a systematic review (SR) of the treatment outcomes of periodontal intrabony defects by using platelet-rich fibrin (PRF) compared with other commonly utilized modalities. The eligibility criteria comprised randomized controlled trials (RCTs) comparing the clinical outcomes of PRF with that of other modalities. Studies were classified into 21 categories and into five different groups as follows: Group I (1) open flap debridement (OFD) alone versus OFD/PRF, (2) OFD versus Titanium-PRF (T-PRF) Group II, (3) Comparative PRF protocols (PRF vs.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!